These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 24819571)

  • 1. Stimulant treatment of ADHD and cigarette smoking: a meta-analysis.
    Schoenfelder EN; Faraone SV; Kollins SH
    Pediatrics; 2014 Jun; 133(6):1070-80. PubMed ID: 24819571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of prior stimulant treatment for attention-deficit/hyperactivity disorder on subsequent risk for cigarette smoking and alcohol and drug use disorders in adolescents.
    Wilens TE; Adamson J; Monuteaux MC; Faraone SV; Schillinger M; Westerberg D; Biederman J
    Arch Pediatr Adolesc Med; 2008 Oct; 162(10):916-21. PubMed ID: 18838643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can we prevent smoking in children with ADHD: a review of the literature.
    Modesto-Lowe V; Danforth JS; Neering C; Easton C
    Conn Med; 2010 Apr; 74(4):229-36. PubMed ID: 20441004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recommendation for Long-term Management of Adult Attention-Deficit/Hyperactivity Disorder in Military Populations, Veterans, and Dependents: A Narrative Review.
    Baughman DJ; Watson CM; Beich JW; Herboso MNJ; Cuttie LK; Marlyne AC
    Mil Med; 2024 May; 189(5-6):e1343-e1352. PubMed ID: 37878798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective study of tobacco smoking and substance dependencies among samples of ADHD and non-ADHD participants.
    Lambert NM; Hartsough CS
    J Learn Disabil; 1998; 31(6):533-44. PubMed ID: 9813951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adult attention-deficit/hyperactivity disorder and nicotine use: a qualitative study of patient perceptions.
    Liebrenz M; Frei A; Fisher CE; Gamma A; Buadze A; Eich D
    BMC Psychiatry; 2014 May; 14():141. PubMed ID: 24885526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of the efficacy of medications for adult attention-deficit/hyperactivity disorder using meta-analysis of effect sizes.
    Faraone SV; Glatt SJ
    J Clin Psychiatry; 2010 Jun; 71(6):754-63. PubMed ID: 20051220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bupropion for attention deficit hyperactivity disorder (ADHD) in adults.
    Verbeeck W; Bekkering GE; Van den Noortgate W; Kramers C
    Cochrane Database Syst Rev; 2017 Oct; 10(10):CD009504. PubMed ID: 28965364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does stimulant therapy of attention-deficit/hyperactivity disorder beget later substance abuse? A meta-analytic review of the literature.
    Wilens TE; Faraone SV; Biederman J; Gunawardene S
    Pediatrics; 2003 Jan; 111(1):179-85. PubMed ID: 12509574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic, Clinical, and Sociodemographic Factors Associated With Stimulant Treatment Outcomes in ADHD.
    Brikell I; Wimberley T; Albiñana C; Pedersen EM; Vilhjálmsson BJ; Agerbo E; Demontis D; Børglum AD; Schork AJ; LaBianca S; Werge T; Mors O; Hougaard DM; Thapar A; Mortensen PB; Dalsgaard S
    Am J Psychiatry; 2021 Sep; 178(9):854-864. PubMed ID: 34154395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnosis and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Council on Scientific Affairs, American Medical Association.
    Goldman LS; Genel M; Bezman RJ; Slanetz PJ
    JAMA; 1998 Apr; 279(14):1100-7. PubMed ID: 9546570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ADHD, stimulant treatment, and growth: a longitudinal study.
    Harstad EB; Weaver AL; Katusic SK; Colligan RC; Kumar S; Chan E; Voigt RG; Barbaresi WJ
    Pediatrics; 2014 Oct; 134(4):e935-44. PubMed ID: 25180281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A qualitative review of issues arising in the use of psycho-stimulant medications in patients with ADHD and co-morbid substance use disorders.
    Kollins SH
    Curr Med Res Opin; 2008 May; 24(5):1345-57. PubMed ID: 18384709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Age of Onset, Duration, and Type of Medication Therapy for Attention-Deficit/Hyperactivity Disorder and Substance Use During Adolescence: A Multi-Cohort National Study.
    McCabe SE; Dickinson K; West BT; Wilens TE
    J Am Acad Child Adolesc Psychiatry; 2016 Jun; 55(6):479-86. PubMed ID: 27238066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Meta-analysis of functional magnetic resonance imaging studies of inhibition and attention in attention-deficit/hyperactivity disorder: exploring task-specific, stimulant medication, and age effects.
    Hart H; Radua J; Nakao T; Mataix-Cols D; Rubia K
    JAMA Psychiatry; 2013 Feb; 70(2):185-98. PubMed ID: 23247506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cocaine or Methamphetamine Use During Young Adulthood Following Stimulant Use for Attention-Deficit/Hyperactivity Disorder During Adolescence.
    McCabe SE; Schulenberg JE; Wilens TE; Schepis TS; McCabe VV; Veliz PT
    JAMA Netw Open; 2023 Jul; 6(7):e2322650. PubMed ID: 37432689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Effects of Long-Acting Stimulant and Nonstimulant Medications in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: A Meta-Analysis of Randomized Controlled Trials.
    Cerrillo-Urbina AJ; García-Hermoso A; Pardo-Guijarro MJ; Sánchez-López M; Santos-Gómez JL; Martínez-Vizcaíno V
    J Child Adolesc Psychopharmacol; 2018 Oct; 28(8):494-507. PubMed ID: 29897263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does the treatment of attention-deficit/hyperactivity disorder with stimulants contribute to drug use/abuse? A 13-year prospective study.
    Barkley RA; Fischer M; Smallish L; Fletcher K
    Pediatrics; 2003 Jan; 111(1):97-109. PubMed ID: 12509561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association Between Stimulant Treatment and Substance Use Through Adolescence Into Early Adulthood.
    Molina BSG; Kennedy TM; Howard AL; Swanson JM; Arnold LE; Mitchell JT; Stehli A; Kennedy EH; Epstein JN; Hechtman LT; Hinshaw SP; Vitiello B
    JAMA Psychiatry; 2023 Sep; 80(9):933-941. PubMed ID: 37405756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of conduct disorder and stimulant medication on later substance use in an ethnically diverse sample of individuals with attention-deficit/hyperactivity disorder in childhood.
    Harty SC; Ivanov I; Newcorn JH; Halperin JM
    J Child Adolesc Psychopharmacol; 2011 Aug; 21(4):331-9. PubMed ID: 21823914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.